• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胸水及腹水中肿瘤细胞的酶细胞化学检测经验(作者译)]

[Experiences with an enzyme cytochemical test for tumor cells in pleural fluid and ascites (author's transl)].

作者信息

Eckert H, Wildner G P

出版信息

Arch Geschwulstforsch. 1979;49(4):305-10.

PMID:496568
Abstract

Experiences with a prescreening test for tumor cells in cytological material (pleural effusions, ascites) are reported. With the aid of alkaline phosphatase positive reacting tumor cells in smears (pleural fluid, ascites) are easily detectable. This test gives a positive result in 65% of patients with different organ tumors whereas with routine cytology tumor cells were found in 72% of this patients. Among different organ tumors highest percentage of positive phosphatase tests are found by bronchial, gastric and ovarial carcinomas (3/4 of cases), to a less degree bycarcinoma of the breast and others (1/2 of cases). All together phosphatase test is positive in 90% of all effusions, containing cytologically diagnosed tumor cells. The adventages, disadventages and the usefullness of this method as a prescreening test are discussed.

摘要

报告了对细胞学材料(胸腔积液、腹水)中肿瘤细胞进行预筛查试验的经验。借助碱性磷酸酶,涂片(胸水、腹水)中反应阳性的肿瘤细胞易于检测到。该试验在65%的不同器官肿瘤患者中呈阳性结果,而常规细胞学检查在这些患者中的肿瘤细胞检出率为72%。在不同器官肿瘤中,支气管癌、胃癌和卵巢癌的磷酸酶试验阳性率最高(3/4的病例),乳腺癌和其他癌症的阳性率较低(1/2的病例)。总体而言,在所有经细胞学诊断含有肿瘤细胞的积液中,磷酸酶试验的阳性率为90%。讨论了该方法作为预筛查试验的优点、缺点和实用性。

相似文献

1
[Experiences with an enzyme cytochemical test for tumor cells in pleural fluid and ascites (author's transl)].[胸水及腹水中肿瘤细胞的酶细胞化学检测经验(作者译)]
Arch Geschwulstforsch. 1979;49(4):305-10.
2
Positive effusion cytology as the initial presentation of malignancy.阳性积液细胞学检查作为恶性肿瘤的初始表现。
Acta Cytol. 1987 Jul-Aug;31(4):448-52.
3
Enzyme cytochemistry of benign and malignant cells in pleural and peritoneal fluid.胸腔和腹腔积液中良性与恶性细胞的酶细胞化学
Acta Cytol. 1967 Nov-Dec;11(6):460-5.
4
[Enzyme cytochemical investigations on pleural effusions (author's transl)].[胸腔积液的酶细胞化学研究(作者译)]
Z Erkr Atmungsorgane. 1977;148(3):321-30.
5
Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.豚鼠和人类肿瘤及炎性渗出液中的血管通透性因子(血管内皮生长因子)
Cancer Res. 1993 Jun 15;53(12):2912-8.
6
The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.恶性疾病患者胸腔或腹腔积液中细胞群体的代谢行为。
Med Interne. 1986 Jul-Sep;24(3):227-33.
7
Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.α-干扰素局部免疫疗法治疗转移性胸腔和腹腔积液:与免疫参数的相关性
Anticancer Res. 1996 Nov-Dec;16(6B):3855-60.
8
The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.恶性肿瘤诊断与积液形成之间的间隔,涉及细胞学诊断的作用。
Acta Cytol. 1988 Mar-Apr;32(2):183-7.
9
The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.胸膜和腹腔积液中恶性肿瘤的细胞学诊断
Acta Cytol. 1987 Mar-Apr;31(2):85-97.
10
Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.癌症和非癌症患者胸腔积液和腹腔积液中的转化生长因子活性。
Jpn J Cancer Res. 1987 Aug;78(8):814-8.